Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Authors
Keywords
Stromal cells, Non-small cell lung cancer, Cell metabolism, Glycolysis, Immunohistochemistry techniques, Vascular surgery, Histology, Surgical oncology
Journal
PLoS One
Volume 9, Issue 9, Pages e105038
Publisher
Public Library of Science (PLoS)
Online
2014-09-17
DOI
10.1371/journal.pone.0105038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)
- (2012) Antônio Talvane Torres de Oliveira et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
- (2012) Pierre Sonveaux et al. PLoS One
- Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors
- (2011) R. Boidot et al. CANCER RESEARCH
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
- (2011) Hiroto Izumi et al. CANCER SCIENCE
- Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment
- (2011) Yanique I. Rattigan et al. EXPERIMENTAL CELL RESEARCH
- Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
- (2011) Tineke W.H. Meijer et al. LUNG CANCER
- Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
- (2011) Sigve Andersen et al. PLoS One
- Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment
- (2011) Morten Busk et al. RADIOTHERAPY AND ONCOLOGY
- Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression
- (2010) Hongmin Chen et al. CLINICAL & EXPERIMENTAL METASTASIS
- Diverging prognostic impacts of hypoxic markers according to NSCLC histology
- (2010) Sigve Andersen et al. LUNG CANCER
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
- (2008) Julia Ling-Yu Chen et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started